Sub navigation menu:


You are here:   You are here > Products > Mirae Asset Horizons Leveraged and Inverse Series > Mirae Asset Horizons Topix Daily (-1X) Inverse Product > Overview

Mirae Asset Horizons Topix Daily (-1X) Inverse Product (Stock Code: 7315)

The Units of Mirae Asset Horizons Topix Daily (-1x) Inverse Product (each the “Terminating Product”) have ceased trading on The Stock Exchange of Hong Kong Limited from 24 May 2018. Please refer to the “Announcement and Notice of the Proposed Cessation of Trading, Termination, Voluntary Deauthorisation and Delisting and Waiver from Strict Compliance of Certain Provisions of the Code” dated 23 April 2018, the subsequent reminder announcements and all other relevant announcements relating to the Terminating Product for further details.

Investment involves risks. Please refer to the Prospectus for details including as to the risk factors.

Mirae Asset Horizons Topix Daily (-1X) Inverse Product ("Product")

Investment risk

  • The Product is a derivative product and not intended for all investors. There is no guarantee of the repayment of principal. Therefore your investment in the Product may suffer substantial/total losses.

Inverse performance risk

  • The Product tracks the inverse Daily performance of the Index. Should the value of the underlying securities of the Index increase, it could have a negative effect on the performance of the Product. Unitholders could, in certain circumstances including a bull market, face minimal or no returns, or may even suffer a complete loss, on such investments.

Long term holding risk

  • The Product is not intended for holding longer than one day as the performance of the Product over a period longer than one day will very likely differ in amount and possibly direction from the inverse performance of the Index over that same period (e.g. the loss may be more than -1 times the increase in the Index).
  • The effect of compounding becomes more pronounced on the Product’s performance as the Index experiences volatility. With higher Index volatility, the deviation of the Product’s performance from the inverse performance of the Index will increase, and the performance of the Product will generally be adversely affected.
  • As a result of Daily rebalancing, the Index’s volatility and the effects of compounding of each day’s return over time, it is even possible that the Product will lose money over time while the Index’s performance falls or is flat.

Inverse Product vs. short selling risk

  • Investing in the Product is different from taking a short position. Because of rebalancing the return profile of the Product is not the same as that of a short position. In a volatile market with frequent directional swings, the performance of the Product may deviate from a short position.

Unconventional return pattern risk

  • Risk investment outcome of the Product is the opposite of conventional investment funds. If the value of the Index increases for extended periods, the Product will likely to lose most or all of its value.

Risk of rebalancing activities

  • There is no assurance that the Product can rebalance its portfolio on a Daily basis to achieve its investment objective. Market disruption, regulatory restrictions or extreme market volatility may adversely affect the Product’s ability to rebalance its portfolio.

Liquidity risk

  • The rebalancing activities of the Product typically take place near the end of a trading day, shortly before the close of the underlying market, to minimise tracking difference. As a result, the Product may be more exposed to the market conditions during a shorter interval and may be more subject to liquidity risk.

Intraday investment risk

  • The Product is normally rebalanced at day end. As such, return for investors that invest for a period less than a full trading day may be greater than or less than the inverse investment exposure to the Index, depending upon the movement of the Index from the last rebalancing until the time of purchase.

Portfolio turnover risk

  • Daily rebalancing of Product’s holdings causes a higher level of portfolio transactions than compared to the conventional ETFs. High levels of transactions increase brokerage and other transaction costs.

Futures contracts risks

  • The Product is a futures based product. Investment in futures contracts involves specific risks such as high volatility, leverage, rollover and margin risks. The leverage component of futures contracts can result in a loss significantly greater than the amount invested in the futures contracts by the Product. Exposures to futures contracts may lead to a high risk of significant loss by the Product.
  • A “roll” occurs when an existing futures contract is about to expire and is replaced with a futures contract representing the same underlying but with a later expiration date. The value of the Product’s portfolio (and so the Net Asset Value per Unit) may be adversely affected by the cost of rolling positions forward as the futures contracts approach expiry.
  • There may be imperfect correlation between the value of the underlying reference assets and the futures contracts, which may prevent the Product from achieving its investment objective.

Japanese market risk

  • The Product’s investments are concentrated in Japan. The value of the Product may be more volatile than that of a fund having a more diverse portfolio of investments. The Japanese economy is heavily dependent on international trade and may be adversely affected by competition from emerging economies, political tensions with its trading partners and their economic conditions, natural disasters and commodity prices. Because of the inverse nature of the Product’s intended returns, any adverse events on the Japanese market may have a favourable impact on the Product’s returns but this cannot be guaranteed. If any such adverse events are resolved without further detrimental effects on the Japanese economy, this may adversely affect the Product’s performance.

Difference in price limit risk

  • The Product’s investment objective is to provide investment results that closely correspond to the inverse (-1x) Daily performance of the Index. Although the Index is an equity index, the Product invests in TOPIX Futures to achieve its investment objective. In Japan, the daily price limit for the stock market and the daily price limit for TOPIX Futures may be different depending on various factors including the share price of individual stocks. As such, should the Index’s daily price movement be greater than the price limit of the TOPIX Futures, the Product may not be able to achieve its investment objective as the TOPIX Futures are unable to deliver a return beyond their price limit.

Currency risk

  • The TOPIX Futures are denominated in JPY, not the base currency of the Product (which is HKD). The Net Asset Value may be affected unfavourably by the fluctuations in the exchange rates between such currency and the base currency and by changes in exchange rate controls.

Passive investments risks

  • The Product is not “actively managed” and therefore the Manager will not have discretion to adapt to market changes when the Index moves in an unfavourable direction to the Product. In such circumstances the Product will also decrease in value.

Trading risks

  • The trading price of the Units on the SEHK is driven by market factors such as the demand and supply of the Units. Therefore, the Units may trade at a substantial premium or discount to the Net Asset Value.
  • As investors will pay certain charges (e.g. trading fees and brokerage fees) to buy or sell Units on the SEHK, investors may pay more than the Net Asset Value per Unit when buying Units on the SEHK, and may receive less than the Net Asset Value per Unit when selling Units on the SEHK.

Trading differences risk

  • As the TSE may be open when the Units are not priced, the value of any TOPIX Futures in the Product’s portfolio, and the value of any constituents in the Index to which such futures contracts are linked, may change when investors may not be able to buy or sell Units. Differences in trading hours between TSE and the SEHK may also increase the level of premium or discount of the Unit price to its Net Asset Value.

Tracking error and correlation risks

  • Due to fees, expenses, transaction costs, high portfolio turnover, liquidity of the market and the investment strategy adopted by the Manager, the correlation between the performance of the Product and the Daily inverse performance of the Index may reduce. The Manager will monitor and seek to manage such risk in minimising tracking error. There can be no assurance of exact or identical replication at any time of the Daily inverse performance of the Index.

Termination risk

  • The Product may be terminated early under certain circumstances, for example, where there is no market maker, the Index is no longer available for benchmarking or if the size of the Product falls below HKD80 million. Any distribution received by a Unitholder on termination of the Product may be less than the capital initially invested by the Unitholder, resulting in a loss to the Unitholder.

Reliance on market maker risks

  • Although it is a requirement that the Manager will ensure that at least one market maker will maintain a market for the Units and gives not less than 3 months’ notice prior to terminating market making arrangement under the relevant market maker agreement, the Product may be required by the SFC to be terminated if there is no market maker for the Units. There is no guarantee that any market making activity will be effective.

All dollar amounts are in HKD and all dates are in GMT+8 Time, unless otherwise specified.

Product objective and investment strategy

The Product seeks to provide investment results that, before deduction of fees and expenses, closely correspond to the inverse (-1x) Daily performance of the Tokyo Stock Price Index (TOPIX) (the “Index”). The Product does not seek to achieve its stated objective over a period of time greater than one day.

"Daily" in relation to the inverse performance of the Index or performance of the Product, means the inverse performance of the Index or performance of the Product (as the case may be) from the close of the relevant market of a given Business Day until the close of the relevant market on the subsequent Business Day.

In seeking to achieve the Product’s investment objective, the Manager will adopt a futures-based replication investment strategy through investing directly in the nearest month TOPIX Futures, subject to the rolling strategy discussed below, to obtain the required exposure to the Index.

In entering the TOPIX Futures each calendar month, the Manager anticipates that not more than 10% of the Net Asset Value of the Product from time to time will be used as margin to acquire the TOPIX Futures.

Not less than 90% of the Net Asset Value of the Product will be invested in cash (HKD and JPY) and cash equivalents (e.g. short term deposits).

The investment strategy of the Product is subject to the investment and borrowing restrictions set out in Part 1 of the Prospectus.


Estimated NAV per Unit [1]

$ --
$ --

Daily NAV per Unit [3] {{ holdasofdate | madate:plocale }}

{{navperunit | currency }}
Change ($)
{{ navchange | currency }}
Change (%)
{{ navpctchange | number:2}} %

Product information {{ navasofdate | madate:plocale}}

Product Inception Date
5 Oct 2016
Listing date on the HKEx
11 Oct 2016
Financial year end of the Product
Ending 31 Mar each year
Ongoing charges over a year
(annual average daily
ongoing charges))
1.35% (0.0054%)
Management Fee
Up to 0.75% per annum of the NAV
Distribution Frequency
The Manager does not intend to pay or make any distributions or dividends
Equity Exposure

Index information [4] {{ indexasofdate | madate:plocale }}

Underlying Index
Tokyo Stock Price Index (TOPIX)
Index Provider
Japan Exchange Group
Type of Index
Price return
Base currency
Closing Level (HKD)
{{ closing }}
Closing Level (JPY)
{{ closingjpy }}
Change (HKD)
{{ pricechange }}
Change %
{{ pctchange | number:2}} %

Trading information {{navasofdate | madate:plocale }}

Hong Kong Stock Exchange
Stock Code
Board Lot Size
200 Units
Trading Currency
Total NAV
{{ navtotal | currency }}
Outstanding Units
{{ navoutstanding | number }}


Daily -1x
Actively Managed
Swap Base
Derivative Base
Securities Lending

Daily Holdings {{ holdasofdate | madate:plocale }}

Total Net Asset Value (HKD)
{{ holdnav | currency }}
Total Value of Futures Contract (HKD) ($)
{{ holdfutvalue | currency }}
Futures Contract Exposure [8] (%)
{{ holdsecpct | number}} %

View all holdings

Participating dealers [5]

  • Mirae Asset Securities (HK) Limited
  • China Merchants Securities (HK) Co., Limited
  • CIMB Securities Ltd
  • KGI Securities (Hong Kong ) Limited
  • Guotai Junan Securities (Hong Kong) Limited
  • BNP Paribas Securities Services
  • Haitong International Securities Company Limited
  • Yue Kun Research Limited
  • ABN AMRO Clearing Hong Kong Limited
Estimated NAV per unit is indicative only and is provided on a 15-second delayed basis by Interactive Data Managed Solutions. (See terms and conditions) and is updated during trading hours of the HKEx.
Market prices are provided on a 15-minute delayed basis by Interactive Data Managed Solutions. (See terms and conditions)
Change indicates the change since the previous business day. For more information on calculation of NAV, please refer to the Prospectus.
Index returns are for illustrative purposes only and should not be taken as an indication or guarantee of future performance. Management fees, transaction costs or other expenses are not reflected in index returns. Change indicates the change since the previous business day's closing index level. (Source: Tokyo Stock Exchange).
Additional Participating Dealer(s) will be appointed from time to time.
Additional Market Maker(s) will be appointed from time to time.
The ongoing charges figure is an annualised figure based on expenses reported in the Sub-Fund’s audited financial statements for the year ended 31 March 2017, expressed as a percentage of the Sub-Fund’s average net asset value over the same period. This figure may vary from year to year. It includes the amortised portion of the set-up costs of the Sub-Fund applicable to the relevant period but excludes any extraordinary expenses. The ongoing charges figure has been capped at a maximum of 1.39% of the average Net Asset Value of the Product since launch. Any ongoing expenses of the Product will be borne by the Manager and will not be charged to the Product if such expense would result in the ongoing charges figure exceeding 1.39%. An increase or removal of the cap is subject to prior approval of the SFC and one month’s prior written notice to Unitholders.
% of Futures Contract in Total asset.
Please note that such a fee may be increased up to a permitted maximum amount by providing 1 month’s prior notice to unitholders. Please refer to the “Fees and Expenses” section of the Prospectus for details.

Back to top